Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray
about
Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue.Proteomic profiling of the retinal dysplasia and degeneration chick retina.Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer.Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MS.Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis.Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferationIntegrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutationEffective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinomaA genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancerProteomic analysis of soft tissue sarcoma.Drug discovery using the regulation of gene expression.Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas.Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer.
P2860
Q33377396-E173382C-FFBE-4ECD-9196-A19557A0F347Q33586379-7F3D0E05-B9DB-47B5-AEBA-FF88B5C8FE18Q34283691-4FFA8094-326B-4498-88A4-D8B64E426E83Q35033878-8B48B08E-762E-443A-B8F0-4EB4859C07ECQ35169992-884D2114-ACEE-493B-B39A-2663A2B5FB26Q36663313-BA09789D-FB81-47E8-913B-75590A208E5DQ37046462-547F7388-2A52-4D25-B41D-DF764A06B2BBQ37575248-163BC0C2-727B-460D-A331-1F7F5C282661Q37739534-F69F7C6B-F9FA-47DA-BCF6-C91A3307485DQ37850740-53E3FDB0-53CF-4748-BE2E-0A0824EB565AQ38088774-A944C289-E4B8-406E-A871-F839F991E8C3Q39130014-DFC59E27-E953-4D31-927A-F63B64792415Q40085654-645EB0C8-CE98-4DC9-85F4-0763C27D6076Q42108269-B10A1F00-3959-4C56-BB4A-461D59D6D10B
P2860
Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification of secernin 1 a ...... on profiles of cDNA microarray
@ast
Identification of secernin 1 a ...... on profiles of cDNA microarray
@en
Identification of secernin 1 a ...... on profiles of cDNA microarray
@nl
type
label
Identification of secernin 1 a ...... on profiles of cDNA microarray
@ast
Identification of secernin 1 a ...... on profiles of cDNA microarray
@en
Identification of secernin 1 a ...... on profiles of cDNA microarray
@nl
prefLabel
Identification of secernin 1 a ...... on profiles of cDNA microarray
@ast
Identification of secernin 1 a ...... on profiles of cDNA microarray
@en
Identification of secernin 1 a ...... on profiles of cDNA microarray
@nl
P2093
P2860
P1433
P1476
Identification of secernin 1 a ...... on profiles of cDNA microarray
@en
P2093
Hideaki Tahara
Naotaka Uchida
Seiji Satoh
Shigetsugu Ohgi
Suguru Hasegawa
Takako Suda
Takeshi Watanabe
Takuya Tsunoda
Yoichi Furukawa
Yusuke Nakamura
P2860
P356
10.1111/J.1349-7006.2006.00194.X
P407
P577
2006-05-01T00:00:00Z